Manel Ramos-Casals

Viruses and lupus: the viral hypothesis
Lupus 2008 17: 163-165. [PDF] [References]  

A Doria and C Briani

Lupus: improving long-term prognosis
Lupus 2008 17: 166-170. [Abstract] [PDF] [References]  

Y Muro, K Sugiura, Y Morita, and Y Tomita

High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody–positive patients with autoimmune rheumatic disease
Lupus 2008 17: 171-176. [Abstract] [PDF] [References]  

R Ramsey-Goldman, GS Alarcón, G McGwin, M Petri, LM Vilá, JC Edberg, JD Reveille, and RP Kimberly, for the PR

Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort
Lupus 2008 17: 177-184. [Abstract] [PDF] [References]  

C Belizna, A Lartigue, J Favre, D Gilbert, F Tron, H Lévesque, C Thuillez, and V Richard

Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
Lupus 2008 17: 185-194. [Abstract] [PDF] [References]  

S-W Lee, M-C Park, Y-B Park, and S-K Lee

E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus
Lupus 2008 17: 195-201. [Abstract] [PDF] [References]  

M Jeffries, G Bruner, S Glenn, P Sadanandan, CW Carson, JB Harley, and AH Sawalha

Sulpha allergy in lupus patients: a clinical perspective
Lupus 2008 17: 202-205. [Abstract] [PDF] [References]  

A Grossman, A Gafter-Gvili, H Green, I Ben Aharon, SM Stemmer, Y Molad, and I Krause

Severe digital ischemia–a presenting symptom of malignancy–associated antiphospholipid syndrome
Lupus 2008 17: 206-209. [Abstract] [PDF] [References]  

T Fukushima, L Dong, T Sakai, T Sawaki, M Miki, M Tanaka, Y Masaki, Y Hirose, M Kuwana, and H Umehara

Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus
Lupus 2008 17: 210-214. [Abstract] [PDF] [References]  

J Al Saleh, M El Sayed, V Jassim, N Mohammed, and N Khan

Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus
Lupus 2008 17: 215-220. [Abstract] [PDF] [References]  

MA Nazarinia, F Ghaffarpasand, A Shamsdin, AA Karimi, N Abbasi, and A Amiri

Systemic lupus erythematosus in the Fars Province of Iran
Lupus 2008 17: 221-227. [Abstract] [PDF] [References]  

D Sánchez-Cano, JL Callejas-Rubio, MA Lara-Jiménez, M López-Trascasa, M Circadi, and N Ortego-Centeno

Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjögren’s syndrome
Lupus 2008 17: 228-229. [PDF] [References]  

David Isenberg, Michael Ehrenstein, and Anisur Rahman

Introduction to a systemic lupus erythematosus – biomarkers meeting held at University College London on 23rd and 24th February 2007
Lupus 2008 17: 231. [PDF]  

A Rahman and BD Stollar

Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases
Lupus 2008 17: 232-235. [PDF] [References]  

M Zouali and RA Mageed

Cellular interactions and signalling defects in lupus (1)
Lupus 2008 17: 236-240. [PDF] [References]  

I Giles and C Putterman

Autoantibodies and other biomarkers – pathological consequences (1)
Lupus 2008 17: 241-246. [PDF] [References]  

SK Datta and C Mauri

Signalling defects and cellular interactions (2)
Lupus 2008 17: 247-250. [PDF] [References]  

LJ Mason and JHM Berden

Pathogenic factors for the development of lupus nephritis
Lupus 2008 17: 251-255. [PDF] [References]  

MR Ehrenstein and JD Alves

Antibodies and other biomarkers – pathological consequences (2)
Lupus 2008 17: 256-258. [PDF] [References]  

Debra Jeske Zack and David Isenberg

Therapeutic potential (1)
Lupus 2008 17: 259-261. [PDF] [References]  

GJ Silverman and MD Linnik

Therapeutic potential (2)
Lupus 2008 17: 262-265. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.